| ID | Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | |
|---|---|---|---|---|---|---|---|---|---|
| GO:0001819 | GO:0001819 | positive regulation of cytokine production | 396 | -0.5437645 | -1.891616 | 0 | 0 | 0 | 4170 |
| GO:0002377 | GO:0002377 | immunoglobulin production | 171 | -0.7441810 | -2.404630 | 0 | 0 | 0 | 2023 |
| GO:0002429 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 429 | -0.6409283 | -2.240673 | 0 | 0 | 0 | 2354 |
| GO:0002431 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 131 | -0.7457044 | -2.347834 | 0 | 0 | 0 | 2061 |
| GO:0002433 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 125 | -0.7543619 | -2.357009 | 0 | 0 | 0 | 2061 |
| GO:0002440 | GO:0002440 | production of molecular mediator of immune response | 252 | -0.6801668 | -2.290847 | 0 | 0 | 0 | 3216 |
| GO:0002449 | GO:0002449 | lymphocyte mediated immunity | 315 | -0.6405384 | -2.197916 | 0 | 0 | 0 | 2112 |
| GO:0002455 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 127 | -0.7486526 | -2.340476 | 0 | 0 | 0 | 1968 |
| GO:0002460 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 325 | -0.6526521 | -2.248977 | 0 | 0 | 0 | 2666 |
| GO:0002696 | GO:0002696 | positive regulation of leukocyte activation | 355 | -0.6014359 | -2.081057 | 0 | 0 | 0 | 3811 |
| GO:0002697 | GO:0002697 | regulation of immune effector process | 422 | -0.5415236 | -1.888603 | 0 | 0 | 0 | 3812 |
| GO:0002757 | GO:0002757 | immune response-activating signal transduction | 429 | -0.6409283 | -2.240673 | 0 | 0 | 0 | 2354 |
| GO:0002764 | GO:0002764 | immune response-regulating signaling pathway | 463 | -0.6334047 | -2.223575 | 0 | 0 | 0 | 2354 |
| GO:0002768 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 460 | -0.6346949 | -2.226791 | 0 | 0 | 0 | 2354 |
| GO:0002920 | GO:0002920 | regulation of humoral immune response | 118 | -0.6813702 | -2.112765 | 0 | 0 | 0 | 1968 |
| GO:0003823 | GO:0003823 | antigen binding | 130 | -0.7394056 | -2.327325 | 0 | 0 | 0 | 2039 |
| GO:0005930 | GO:0005930 | axoneme | 121 | 0.6380063 | 2.285192 | 0 | 0 | 0 | 3801 |
| GO:0006898 | GO:0006898 | receptor-mediated endocytosis | 301 | -0.6331288 | -2.167733 | 0 | 0 | 0 | 1970 |
| GO:0006909 | GO:0006909 | phagocytosis | 338 | -0.6558300 | -2.260057 | 0 | 0 | 0 | 2496 |
| GO:0006911 | GO:0006911 | phagocytosis, engulfment | 104 | -0.7692759 | -2.345129 | 0 | 0 | 0 | 1933 |
| GO:0006956 | GO:0006956 | complement activation | 142 | -0.7245575 | -2.300670 | 0 | 0 | 0 | 1937 |
| GO:0006958 | GO:0006958 | complement activation, classical pathway | 112 | -0.7625066 | -2.346198 | 0 | 0 | 0 | 1937 |
| GO:0006959 | GO:0006959 | humoral immune response | 287 | -0.6101941 | -2.082021 | 0 | 0 | 0 | 2343 |
| GO:0007018 | GO:0007018 | microtubule-based movement | 343 | 0.4780596 | 1.921212 | 0 | 0 | 0 | 4605 |
| GO:0008037 | GO:0008037 | cell recognition | 199 | -0.6120655 | -2.007851 | 0 | 0 | 0 | 2150 |
| GO:0009897 | GO:0009897 | external side of plasma membrane | 358 | -0.6154264 | -2.130194 | 0 | 0 | 0 | 3703 |
| GO:0010324 | GO:0010324 | membrane invagination | 120 | -0.7509297 | -2.334092 | 0 | 0 | 0 | 1933 |
| GO:0016064 | GO:0016064 | immunoglobulin mediated immune response | 191 | -0.7176371 | -2.354378 | 0 | 0 | 0 | 1968 |
| GO:0019724 | GO:0019724 | B cell mediated immunity | 194 | -0.7159163 | -2.344725 | 0 | 0 | 0 | 1968 |
| GO:0019814 | GO:0019814 | immunoglobulin complex | 121 | -0.8466625 | -2.641557 | 0 | 0 | 0 | 1933 |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| hsa04060 | Cytokine-cytokine receptor interaction | 237 | -0.5728888 | -1.934321 | 0.0000000 | 0.0000004 | 0.0000004 | 3661 | tags=46%, list=17%, signal=38% |
| hsa04380 | Osteoclast differentiation | 116 | -0.6187328 | -1.936975 | 0.0000002 | 0.0000400 | 0.0000362 | 4483 | tags=42%, list=21%, signal=34% |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 84 | -0.6492343 | -1.954523 | 0.0000013 | 0.0001354 | 0.0001227 | 3357 | tags=54%, list=15%, signal=46% |
| hsa05143 | African trypanosomiasis | 34 | -0.7314140 | -1.906165 | 0.0000957 | 0.0077550 | 0.0070294 | 2996 | tags=50%, list=14%, signal=43% |
| hsa05144 | Malaria | 45 | -0.6691906 | -1.829394 | 0.0002593 | 0.0168045 | 0.0152321 | 2996 | tags=44%, list=14%, signal=38% |
| hsa04062 | Chemokine signaling pathway | 172 | -0.4892680 | -1.602290 | 0.0003909 | 0.0211089 | 0.0191338 | 3082 | tags=27%, list=14%, signal=23% |
| hsa04145 | Phagosome | 133 | -0.5084017 | -1.618602 | 0.0005194 | 0.0240410 | 0.0217916 | 2991 | tags=25%, list=14%, signal=22% |
| hsa04625 | C-type lectin receptor signaling pathway | 96 | -0.5496769 | -1.672728 | 0.0006067 | 0.0245732 | 0.0222739 | 4225 | tags=32%, list=19%, signal=26% |
| hsa05152 | Tuberculosis | 155 | -0.4868189 | -1.573718 | 0.0007506 | 0.0270228 | 0.0244944 | 4942 | tags=34%, list=23%, signal=26% |
| hsa04080 | Neuroactive ligand-receptor interaction | 272 | -0.4341123 | -1.479482 | 0.0010016 | 0.0324516 | 0.0294152 | 2804 | tags=31%, list=13%, signal=27% |
| hsa04662 | B cell receptor signaling pathway | 73 | -0.5636494 | -1.651019 | 0.0016835 | 0.0495854 | 0.0449459 | 3655 | tags=27%, list=17%, signal=23% |
| hsa05205 | Proteoglycans in cancer | 199 | -0.4471671 | -1.484681 | 0.0022090 | 0.0596421 | 0.0540616 | 3732 | tags=24%, list=17%, signal=20% |
| hsa05340 | Primary immunodeficiency | 33 | -0.6626406 | -1.725614 | 0.0029925 | 0.0662150 | 0.0600195 | 3094 | tags=61%, list=14%, signal=52% |
| hsa05414 | Dilated cardiomyopathy | 92 | -0.5247765 | -1.596397 | 0.0030361 | 0.0662150 | 0.0600195 | 3523 | tags=34%, list=16%, signal=28% |
| hsa04659 | Th17 cell differentiation | 101 | -0.5054507 | -1.549432 | 0.0030655 | 0.0662150 | 0.0600195 | 4024 | tags=36%, list=18%, signal=29% |
| hsa04666 | Fc gamma R-mediated phagocytosis | 92 | -0.5170513 | -1.572896 | 0.0042907 | 0.0868858 | 0.0787562 | 4308 | tags=25%, list=20%, signal=20% |
| hsa04730 | Long-term depression | 57 | -0.5749751 | -1.630755 | 0.0051956 | 0.0948724 | 0.0859955 | 4605 | tags=39%, list=21%, signal=31% |
| hsa03010 | Ribosome | 126 | 0.4154256 | 1.481365 | 0.0052707 | 0.0948724 | 0.0859955 | 8549 | tags=71%, list=39%, signal=44% |
| hsa04360 | Axon guidance | 174 | -0.4432090 | -1.454350 | 0.0060811 | 0.1029028 | 0.0932745 | 5744 | tags=39%, list=26%, signal=29% |
| hsa04514 | Cell adhesion molecules | 143 | -0.4644479 | -1.496108 | 0.0063520 | 0.1029028 | 0.0932745 | 3446 | tags=37%, list=16%, signal=31% |
| hsa05410 | Hypertrophic cardiomyopathy | 88 | -0.5096512 | -1.548758 | 0.0067624 | 0.1043339 | 0.0945717 | 3523 | tags=34%, list=16%, signal=29% |
| hsa04613 | Neutrophil extracellular trap formation | 135 | -0.4577221 | -1.461744 | 0.0084436 | 0.1175908 | 0.1065881 | 2231 | tags=17%, list=10%, signal=15% |
| hsa04974 | Protein digestion and absorption | 92 | -0.5007167 | -1.523205 | 0.0086237 | 0.1175908 | 0.1065881 | 4470 | tags=47%, list=20%, signal=37% |
| hsa05321 | Inflammatory bowel disease | 62 | -0.5469064 | -1.567591 | 0.0092254 | 0.1175908 | 0.1065881 | 3827 | tags=42%, list=18%, signal=35% |
| hsa04658 | Th1 and Th2 cell differentiation | 85 | -0.4985516 | -1.503809 | 0.0092539 | 0.1175908 | 0.1065881 | 4024 | tags=38%, list=18%, signal=31% |
| hsa05150 | Staphylococcus aureus infection | 71 | -0.5267601 | -1.538898 | 0.0094363 | 0.1175908 | 0.1065881 | 2494 | tags=37%, list=11%, signal=33% |
| hsa05140 | Leishmaniasis | 72 | -0.5219597 | -1.526111 | 0.0111411 | 0.1336929 | 0.1211836 | 2996 | tags=31%, list=14%, signal=26% |
| hsa04650 | Natural killer cell mediated cytotoxicity | 97 | -0.4750737 | -1.445189 | 0.0155714 | 0.1801833 | 0.1633240 | 3149 | tags=39%, list=14%, signal=34% |
| hsa05226 | Gastric cancer | 140 | -0.4361604 | -1.402568 | 0.0180397 | 0.2015475 | 0.1826893 | 4955 | tags=30%, list=23%, signal=23% |
| hsa04270 | Vascular smooth muscle contraction | 123 | -0.4422695 | -1.398689 | 0.0189871 | 0.2050609 | 0.1858739 | 5715 | tags=45%, list=26%, signal=33% |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| WP4803 | Ciliopathies | 174 | 0.5151399 | 1.931770 | 0.0000000 | 0.0000236 | 0.0000216 | 5577 | tags=63%, list=26%, signal=47% |
| WP4536 | Genes related to primary cilium development (based on CRISPR) | 100 | 0.5335058 | 1.879537 | 0.0000186 | 0.0051748 | 0.0047332 | 7296 | tags=74%, list=33%, signal=49% |
| WP5055 | Burn wound healing | 95 | -0.5742072 | -1.752016 | 0.0000546 | 0.0101434 | 0.0092779 | 4582 | tags=51%, list=21%, signal=40% |
| WP455 | GPCRs, class A rhodopsin-like | 177 | -0.5037587 | -1.646494 | 0.0001087 | 0.0151380 | 0.0138464 | 2612 | tags=36%, list=12%, signal=32% |
| WP3945 | TYROBP causal network in microglia | 59 | -0.6313851 | -1.807226 | 0.0001540 | 0.0171534 | 0.0156898 | 5367 | tags=56%, list=25%, signal=42% |
| WP3937 | Microglia pathogen phagocytosis pathway | 36 | -0.7042751 | -1.855815 | 0.0002573 | 0.0219657 | 0.0200915 | 1994 | tags=36%, list=9%, signal=33% |
| WP5095 | Overview of proinflammatory and profibrotic mediators | 86 | -0.5681335 | -1.707930 | 0.0003127 | 0.0219657 | 0.0200915 | 2996 | tags=48%, list=14%, signal=41% |
| WP3929 | Chemokine signaling pathway | 153 | -0.5020828 | -1.618328 | 0.0003155 | 0.0219657 | 0.0200915 | 3321 | tags=27%, list=15%, signal=23% |
| WP2873 | Aryl hydrocarbon receptor pathway | 40 | -0.6614129 | -1.780444 | 0.0005981 | 0.0370133 | 0.0338552 | 3615 | tags=40%, list=17%, signal=33% |
| WP129 | Matrix metalloproteinases | 28 | -0.7198671 | -1.804588 | 0.0007881 | 0.0430571 | 0.0393832 | 3091 | tags=50%, list=14%, signal=43% |
| WP477 | Cytoplasmic ribosomal proteins | 86 | 0.4845100 | 1.655067 | 0.0008503 | 0.0430571 | 0.0393832 | 7695 | tags=78%, list=35%, signal=51% |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 115 | -0.6885328 | -2.152382 | 0.0000000 | 0.0000001 | 0.0000001 | 3226 | tags=49%, list=15%, signal=42% |
| R-HSA-6798695 | Neutrophil degranulation | 451 | -0.4907592 | -1.715590 | 0.0000000 | 0.0000052 | 0.0000050 | 3124 | tags=20%, list=14%, signal=17% |
| R-HSA-500792 | GPCR ligand binding | 366 | -0.4903742 | -1.698256 | 0.0000001 | 0.0000543 | 0.0000528 | 3084 | tags=36%, list=14%, signal=31% |
| R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 263 | -0.5124662 | -1.724093 | 0.0000003 | 0.0001125 | 0.0001094 | 3084 | tags=38%, list=14%, signal=33% |
| R-HSA-375276 | Peptide ligand-binding receptors | 155 | -0.5316774 | -1.724738 | 0.0000146 | 0.0043237 | 0.0042036 | 2529 | tags=42%, list=12%, signal=37% |
| R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 41 | -0.7104568 | -1.911377 | 0.0000566 | 0.0139539 | 0.0135660 | 3312 | tags=56%, list=15%, signal=48% |
| R-HSA-380108 | Chemokine receptors bind chemokines | 49 | -0.6860329 | -1.893186 | 0.0000771 | 0.0162979 | 0.0158450 | 3321 | tags=59%, list=15%, signal=50% |
| R-HSA-1474228 | Degradation of the extracellular matrix | 133 | -0.5280464 | -1.687558 | 0.0002110 | 0.0389995 | 0.0379156 | 4867 | tags=46%, list=22%, signal=36% |
| R-HSA-1442490 | Collagen degradation | 61 | -0.6298463 | -1.796123 | 0.0002487 | 0.0408761 | 0.0397400 | 5375 | tags=62%, list=25%, signal=47% |
| R-HSA-1474244 | Extracellular matrix organization | 288 | -0.4387761 | -1.490951 | 0.0004343 | 0.0642335 | 0.0624482 | 5100 | tags=47%, list=23%, signal=36% |
| R-HSA-5660526 | Response to metal ions | 10 | 0.8466431 | 1.829864 | 0.0008172 | 0.1098793 | 0.1068255 | 1688 | tags=70%, list=8%, signal=65% |
| R-HSA-5654706 | FRS-mediated FGFR3 signaling | 18 | -0.7664477 | -1.753410 | 0.0014480 | 0.1319155 | 0.1282492 | 2671 | tags=39%, list=12%, signal=34% |
| R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 105 | 0.4513058 | 1.595706 | 0.0015776 | 0.1319155 | 0.1282492 | 8285 | tags=76%, list=38%, signal=47% |
| R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 106 | 0.4479969 | 1.584252 | 0.0015846 | 0.1319155 | 0.1282492 | 8285 | tags=75%, list=38%, signal=47% |
| R-HSA-8948216 | Collagen chain trimerization | 43 | -0.6351886 | -1.718056 | 0.0016029 | 0.1319155 | 0.1282492 | 4366 | tags=58%, list=20%, signal=47% |
| R-HSA-156902 | Peptide chain elongation | 85 | 0.4726191 | 1.638073 | 0.0017129 | 0.1319155 | 0.1282492 | 7725 | tags=78%, list=35%, signal=50% |
| R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 66 | -0.5775922 | -1.675247 | 0.0017580 | 0.1319155 | 0.1282492 | 4366 | tags=50%, list=20%, signal=40% |
| R-HSA-192823 | Viral mRNA Translation | 85 | 0.4704329 | 1.630496 | 0.0018434 | 0.1319155 | 0.1282492 | 7725 | tags=76%, list=35%, signal=50% |
| R-HSA-202733 | Cell surface interactions at the vascular wall | 122 | -0.4933475 | -1.552663 | 0.0019174 | 0.1319155 | 0.1282492 | 3761 | tags=28%, list=17%, signal=23% |
| R-HSA-72613 | Eukaryotic Translation Initiation | 113 | 0.4454122 | 1.593479 | 0.0019211 | 0.1319155 | 0.1282492 | 8285 | tags=73%, list=38%, signal=45% |
| R-HSA-72737 | Cap-dependent Translation Initiation | 113 | 0.4454122 | 1.593479 | 0.0019211 | 0.1319155 | 0.1282492 | 8285 | tags=73%, list=38%, signal=45% |
| R-HSA-2408557 | Selenocysteine synthesis | 89 | 0.4680878 | 1.627473 | 0.0019622 | 0.1319155 | 0.1282492 | 7725 | tags=75%, list=35%, signal=49% |
| R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 97 | 0.4579798 | 1.605021 | 0.0020549 | 0.1321399 | 0.1284674 | 7725 | tags=73%, list=35%, signal=47% |
| R-HSA-2408522 | Selenoamino acid metabolism | 111 | 0.4378874 | 1.560744 | 0.0022732 | 0.1400878 | 0.1361944 | 7725 | tags=67%, list=35%, signal=43% |
| R-HSA-72764 | Eukaryotic Translation Termination | 89 | 0.4579869 | 1.592354 | 0.0027867 | 0.1446001 | 0.1405813 | 7725 | tags=74%, list=35%, signal=48% |
| R-HSA-3000480 | Scavenging by Class A Receptors | 19 | -0.7412537 | -1.707823 | 0.0028152 | 0.1446001 | 0.1405813 | 3045 | tags=58%, list=14%, signal=50% |
| R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 106 | 0.4340876 | 1.535065 | 0.0028167 | 0.1446001 | 0.1405813 | 8242 | tags=69%, list=38%, signal=43% |
| R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 106 | 0.4340876 | 1.535065 | 0.0028167 | 0.1446001 | 0.1405813 | 8242 | tags=69%, list=38%, signal=43% |
| R-HSA-2172127 | DAP12 interactions | 34 | -0.6568122 | -1.712451 | 0.0028800 | 0.1446001 | 0.1405813 | 2659 | tags=32%, list=12%, signal=28% |
| R-HSA-72689 | Formation of a pool of free 40S subunits | 97 | 0.4517202 | 1.583084 | 0.0029331 | 0.1446001 | 0.1405813 | 8285 | tags=78%, list=38%, signal=49% |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| DOID:37 | skin disease | 304 | -0.5441697 | -1.857470 | 0.0000000 | 0.0000003 | 0.0000002 | 3795 | tags=36%, list=17%, signal=30% |
| DOID:16 | integumentary system disease | 344 | -0.5237988 | -1.799146 | 0.0000000 | 0.0000003 | 0.0000002 | 3795 | tags=35%, list=17%, signal=29% |
| DOID:7148 | rheumatoid arthritis | 491 | -0.4850823 | -1.698319 | 0.0000000 | 0.0000003 | 0.0000002 | 4515 | tags=36%, list=21%, signal=29% |
| DOID:2723 | dermatitis | 154 | -0.5981187 | -1.925163 | 0.0000000 | 0.0000031 | 0.0000023 | 2996 | tags=39%, list=14%, signal=34% |
| DOID:850 | lung disease | 448 | -0.4567010 | -1.596029 | 0.0000015 | 0.0001963 | 0.0001434 | 3851 | tags=32%, list=18%, signal=27% |
| DOID:0050161 | lower respiratory tract disease | 457 | -0.4539550 | -1.589149 | 0.0000023 | 0.0002485 | 0.0001815 | 3851 | tags=32%, list=18%, signal=27% |
| DOID:3310 | atopic dermatitis | 123 | -0.5959388 | -1.859411 | 0.0000026 | 0.0002485 | 0.0001815 | 2996 | tags=39%, list=14%, signal=34% |
| DOID:0050737 | autosomal recessive disease | 304 | -0.4853740 | -1.656777 | 0.0000032 | 0.0002641 | 0.0001929 | 2996 | tags=24%, list=14%, signal=21% |
| DOID:104 | bacterial infectious disease | 232 | -0.5157119 | -1.728091 | 0.0000048 | 0.0003537 | 0.0002583 | 3226 | tags=33%, list=15%, signal=28% |
| DOID:74 | hematopoietic system disease | 430 | -0.4442370 | -1.547017 | 0.0000086 | 0.0005699 | 0.0004163 | 3706 | tags=29%, list=17%, signal=24% |
| DOID:2349 | arteriosclerosis | 321 | -0.4602345 | -1.573708 | 0.0000153 | 0.0009202 | 0.0006721 | 4291 | tags=36%, list=20%, signal=30% |
| DOID:0050338 | primary bacterial infectious disease | 203 | -0.5092871 | -1.682387 | 0.0000199 | 0.0010927 | 0.0007982 | 3226 | tags=33%, list=15%, signal=28% |
| DOID:170 | endocrine gland cancer | 476 | -0.4300668 | -1.505744 | 0.0000231 | 0.0011748 | 0.0008582 | 3931 | tags=28%, list=18%, signal=23% |
| DOID:1936 | atherosclerosis | 310 | -0.4567575 | -1.561612 | 0.0000561 | 0.0026424 | 0.0019302 | 4251 | tags=36%, list=19%, signal=30% |
| DOID:0070004 | myeloma | 296 | -0.4613705 | -1.572658 | 0.0000621 | 0.0027322 | 0.0019958 | 4395 | tags=36%, list=20%, signal=30% |
| DOID:3213 | demyelinating disease | 159 | -0.5143553 | -1.658572 | 0.0000978 | 0.0040337 | 0.0029465 | 4866 | tags=46%, list=22%, signal=36% |
| DOID:0060005 | autoimmune disease of endocrine system | 81 | -0.5958219 | -1.753721 | 0.0001071 | 0.0041588 | 0.0030378 | 3163 | tags=41%, list=14%, signal=35% |
| DOID:2348 | arteriosclerotic cardiovascular disease | 311 | -0.4559921 | -1.559441 | 0.0001270 | 0.0043696 | 0.0031918 | 4251 | tags=36%, list=19%, signal=29% |
| DOID:10241 | thalassemia | 42 | -0.6927320 | -1.876801 | 0.0001284 | 0.0043696 | 0.0031918 | 1180 | tags=24%, list=5%, signal=23% |
| DOID:526 | Human immunodeficiency virus infectious disease | 156 | -0.5141764 | -1.653475 | 0.0001385 | 0.0043696 | 0.0031918 | 3795 | tags=33%, list=17%, signal=28% |
| DOID:4960 | bone marrow cancer | 301 | -0.4578960 | -1.562517 | 0.0001390 | 0.0043696 | 0.0031918 | 4395 | tags=36%, list=20%, signal=29% |
| DOID:28 | endocrine system disease | 342 | -0.4378120 | -1.503976 | 0.0001514 | 0.0044404 | 0.0032436 | 3163 | tags=27%, list=14%, signal=23% |
| DOID:1883 | hepatitis C | 211 | -0.4812333 | -1.601759 | 0.0001547 | 0.0044404 | 0.0032436 | 3154 | tags=27%, list=14%, signal=24% |
| DOID:50 | thyroid gland disease | 144 | -0.5144514 | -1.636812 | 0.0001940 | 0.0053347 | 0.0038968 | 3714 | tags=36%, list=17%, signal=30% |
| DOID:1398 | parasitic infectious disease | 130 | -0.5231347 | -1.640957 | 0.0002270 | 0.0059264 | 0.0043290 | 4278 | tags=43%, list=20%, signal=35% |
| DOID:9538 | multiple myeloma | 241 | -0.4653044 | -1.563090 | 0.0002423 | 0.0059264 | 0.0043290 | 4448 | tags=36%, list=20%, signal=29% |
| DOID:403 | mouth disease | 164 | -0.5004962 | -1.621306 | 0.0002451 | 0.0059264 | 0.0043290 | 3262 | tags=35%, list=15%, signal=30% |
| DOID:2320 | obstructive lung disease | 279 | -0.4562386 | -1.549021 | 0.0002514 | 0.0059264 | 0.0043290 | 3360 | tags=30%, list=15%, signal=26% |
| DOID:9778 | irritable bowel syndrome | 68 | -0.5999453 | -1.740745 | 0.0002788 | 0.0063451 | 0.0046349 | 3703 | tags=41%, list=17%, signal=34% |
| DOID:7998 | hyperthyroidism | 89 | -0.5623924 | -1.682362 | 0.0002896 | 0.0063703 | 0.0046533 | 3163 | tags=37%, list=14%, signal=32% |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| neuroblastoma | neuroblastoma | 55 | -0.5503364 | -1.5583495 | 0.0103474 | 0.5294026 | 0.5234923 | 4272 | tags=35%, list=20%, signal=28% |
| small_cell_lung_cancer | small_cell_lung_cancer | 48 | -0.5457921 | -1.5029106 | 0.0177137 | 0.5294026 | 0.5234923 | 2103 | tags=35%, list=10%, signal=32% |
| squamous_head_and_neck_cancer | squamous_head_and_neck_cancer | 106 | -0.4469183 | -1.3806279 | 0.0240638 | 0.5294026 | 0.5234923 | 4303 | tags=35%, list=20%, signal=28% |
| cutaneous_DLBCL | cutaneous_DLBCL | 21 | -0.6323672 | -1.5012498 | 0.0460751 | 0.7602389 | 0.7517514 | 2810 | tags=29%, list=13%, signal=25% |
| cutaneous_T_cell_lymphoma | cutaneous_T_cell_lymphoma | 25 | -0.5639416 | -1.3876083 | 0.0861789 | 1.0000000 | 0.9888357 | 5318 | tags=60%, list=24%, signal=45% |
| acute_promyelocytic_leukemia | acute_promyelocytic_leukemia | 29 | -0.5463150 | -1.3857295 | 0.0956938 | 1.0000000 | 0.9888357 | 5121 | tags=34%, list=23%, signal=26% |
| Burkitt's_lymphoma | Burkitt's_lymphoma | 21 | -0.5582202 | -1.3252237 | 0.1331058 | 1.0000000 | 0.9888357 | 1992 | tags=33%, list=9%, signal=30% |
| desmoplastic_melanoma | desmoplastic_melanoma | 24 | -0.5353084 | -1.3073673 | 0.1414309 | 1.0000000 | 0.9888357 | 708 | tags=21%, list=3%, signal=20% |
| juvenile_myelomonocytic_leukemia | juvenile_myelomonocytic_leukemia | 16 | -0.5876466 | -1.3120453 | 0.1443478 | 1.0000000 | 0.9888357 | 4865 | tags=31%, list=22%, signal=24% |
| esophageal_squamous_carcinoma | esophageal_squamous_carcinoma | 42 | -0.4575009 | -1.2248149 | 0.1886792 | 1.0000000 | 0.9888357 | 4474 | tags=43%, list=21%, signal=34% |
| glioblastoma | glioblastoma | 107 | 0.3170657 | 1.1245008 | 0.2022059 | 1.0000000 | 0.9888357 | 753 | tags=8%, list=3%, signal=8% |
| T-cell_leukemia/lymphoma | T-cell_leukemia/lymphoma | 49 | -0.4279030 | -1.1857387 | 0.2233883 | 1.0000000 | 0.9888357 | 5182 | tags=35%, list=24%, signal=27% |
| chronic_lymphocytic_leukemia | chronic_lymphocytic_leukemia | 108 | -0.3629755 | -1.1226889 | 0.2735978 | 1.0000000 | 0.9888357 | 4251 | tags=28%, list=19%, signal=22% |
| pancreatic_ductal_adenocarcinoma | pancreatic_ductal_adenocarcinoma | 150 | -0.3433403 | -1.0958340 | 0.2752294 | 1.0000000 | 0.9888357 | 3779 | tags=23%, list=17%, signal=19% |
| esophageal_adenocarcinoma | esophageal_adenocarcinoma | 42 | -0.4214600 | -1.1283267 | 0.3018868 | 1.0000000 | 0.9888357 | 2578 | tags=21%, list=12%, signal=19% |
| pan-cancer_paediatric | pan-cancer_paediatric | 174 | -0.3345652 | -1.0847952 | 0.3029151 | 1.0000000 | 0.9888357 | 4576 | tags=20%, list=21%, signal=16% |
| soft_tissue_sarcoma | soft_tissue_sarcoma | 25 | -0.4609154 | -1.1341069 | 0.3138211 | 1.0000000 | 0.9888357 | 4251 | tags=40%, list=19%, signal=32% |
| skin_basal_cell_carcinoma | skin_basal_cell_carcinoma | 25 | -0.4291984 | -1.0560654 | 0.3886179 | 1.0000000 | 0.9888357 | 4344 | tags=32%, list=20%, signal=26% |
| ovarian_cancer | ovarian_cancer | 16 | -0.4765402 | -1.0639767 | 0.3930435 | 1.0000000 | 0.9888357 | 5458 | tags=38%, list=25%, signal=28% |
| natural_killer/T_cell_lymphoma | natural_killer/T_cell_lymphoma | 25 | -0.4248910 | -1.0454669 | 0.3983740 | 1.0000000 | 0.9888357 | 6191 | tags=40%, list=28%, signal=29% |
| melanoma | melanoma | 127 | -0.3198396 | -1.0071912 | 0.4401596 | 1.0000000 | 0.9888357 | 4831 | tags=25%, list=22%, signal=20% |
| paediatric_low_grade_glioma | paediatric_low_grade_glioma | 33 | -0.3943560 | -1.0188613 | 0.4414557 | 1.0000000 | 0.9888357 | 4758 | tags=33%, list=22%, signal=26% |
| non-small_cell_lung_cancer | non-small_cell_lung_cancer | 25 | -0.4103357 | -1.0096527 | 0.4455285 | 1.0000000 | 0.9888357 | 5966 | tags=48%, list=27%, signal=35% |
| lung_cancer_(all_histologies) | lung_cancer_(all_histologies) | 90 | -0.3341799 | -1.0076238 | 0.4498607 | 1.0000000 | 0.9888357 | 5966 | tags=29%, list=27%, signal=21% |
| triple_negative_breast_cancer | triple_negative_breast_cancer | 75 | -0.3378662 | -0.9940391 | 0.4837341 | 1.0000000 | 0.9888357 | 4805 | tags=23%, list=22%, signal=18% |
| colorectal_adenocarcinoma | colorectal_adenocarcinoma | 150 | -0.2961113 | -0.9450940 | 0.5766710 | 1.0000000 | 0.9888357 | 3619 | tags=19%, list=17%, signal=16% |
| pan-liver | pan-liver | 28 | -0.3597050 | -0.9074588 | 0.5961538 | 1.0000000 | 0.9888357 | 1495 | tags=36%, list=7%, signal=33% |
| esophageal_(squamous_and_adenocarcinoma) | esophageal_(squamous_and_adenocarcinoma) | 17 | -0.4035685 | -0.9085658 | 0.6052632 | 1.0000000 | 0.9888357 | 5966 | tags=35%, list=27%, signal=26% |
| acute_lymphoblastic_leukemia | acute_lymphoblastic_leukemia | 49 | -0.3245775 | -0.8994191 | 0.6251874 | 1.0000000 | 0.9888357 | 5032 | tags=31%, list=23%, signal=24% |
| chronic_myeloid_leukemia | chronic_myeloid_leukemia | 28 | -0.3431107 | -0.8655949 | 0.6538462 | 1.0000000 | 0.9888357 | 2737 | tags=14%, list=13%, signal=13% |
| Description | setSize | enrichmentScore | NES | pvalue | p.adjust | qvalues | rank | leading_edge | |
|---|---|---|---|---|---|---|---|---|---|
| C4551906 | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 40 | 0.7877550 | 2.358369 | 0.0e+00 | 0.0000119 | 0.0000103 | 4344 | tags=92%, list=20%, signal=74% |
| C0271994 | Hereditary persistence of fetal hemoglobin thalassemia | 28 | -0.8729034 | -2.207257 | 0.0e+00 | 0.0000119 | 0.0000103 | 46 | tags=18%, list=0%, signal=18% |
| C0021368 | Inflammation | 422 | -0.4894970 | -1.704487 | 0.0e+00 | 0.0000119 | 0.0000103 | 4251 | tags=38%, list=19%, signal=31% |
| C0409974 | Lupus Erythematosus | 476 | -0.4784378 | -1.675145 | 0.0e+00 | 0.0000197 | 0.0000171 | 4260 | tags=33%, list=20%, signal=27% |
| C1855672 | Immotile cilia | 37 | 0.7911813 | 2.331074 | 0.0e+00 | 0.0000197 | 0.0000171 | 4344 | tags=95%, list=20%, signal=76% |
| C4703436 | Impaired nasal mucociliary clearance | 37 | 0.7911813 | 2.331074 | 0.0e+00 | 0.0000197 | 0.0000171 | 4344 | tags=95%, list=20%, signal=76% |
| C0024138 | Lupus Erythematosus, Discoid | 469 | -0.4776091 | -1.671969 | 0.0e+00 | 0.0000197 | 0.0000171 | 4260 | tags=33%, list=20%, signal=27% |
| C0024131 | Lupus Vulgaris | 445 | -0.4789220 | -1.672634 | 0.0e+00 | 0.0000261 | 0.0000226 | 4175 | tags=32%, list=19%, signal=27% |
| C0037284 | Skin lesion | 488 | -0.4691077 | -1.645420 | 0.0e+00 | 0.0000261 | 0.0000226 | 4335 | tags=34%, list=20%, signal=28% |
| C0022521 | Kartagener Syndrome | 62 | 0.6985629 | 2.277271 | 0.0e+00 | 0.0000261 | 0.0000226 | 4469 | tags=79%, list=20%, signal=63% |
| C0031090 | Periodontal Diseases | 282 | -0.5180367 | -1.757942 | 0.0e+00 | 0.0000261 | 0.0000226 | 3851 | tags=39%, list=18%, signal=32% |
| C0026896 | Myasthenia Gravis | 289 | -0.5241955 | -1.781566 | 0.0e+00 | 0.0000261 | 0.0000226 | 3844 | tags=38%, list=18%, signal=32% |
| C0398650 | Immune thrombocytopenic purpura | 279 | -0.5182311 | -1.759283 | 1.0e-07 | 0.0000261 | 0.0000226 | 3550 | tags=36%, list=16%, signal=31% |
| C4317124 | Polynesian Bronchiectasis | 33 | 0.7917827 | 2.252494 | 1.0e-07 | 0.0000297 | 0.0000257 | 4300 | tags=94%, list=20%, signal=76% |
| C0002895 | Anemia, Sickle Cell | 374 | -0.4876633 | -1.689971 | 1.0e-07 | 0.0000608 | 0.0000527 | 2996 | tags=23%, list=14%, signal=20% |
| C0018520 | Halitosis | 44 | 0.7347740 | 2.268959 | 2.0e-07 | 0.0000717 | 0.0000621 | 4344 | tags=86%, list=20%, signal=69% |
| C0003862 | Arthralgia | 233 | -0.5308531 | -1.779000 | 2.0e-07 | 0.0000840 | 0.0000728 | 4169 | tags=35%, list=19%, signal=29% |
| C0037299 | Skin Ulcer | 141 | -0.5907092 | -1.894404 | 4.0e-07 | 0.0001330 | 0.0001152 | 4625 | tags=38%, list=21%, signal=30% |
| C0867389 | Chronic graft-versus-host disease | 205 | -0.5401337 | -1.787557 | 4.0e-07 | 0.0001488 | 0.0001289 | 3154 | tags=32%, list=14%, signal=28% |
| C0008780 | Ciliary Motility Disorders | 52 | 0.6972746 | 2.226624 | 5.0e-07 | 0.0001566 | 0.0001357 | 4344 | tags=75%, list=20%, signal=60% |
| C0036202 | Sarcoidosis | 350 | -0.4842089 | -1.677871 | 5.0e-07 | 0.0001566 | 0.0001357 | 3844 | tags=31%, list=18%, signal=26% |
| C0011603 | Dermatitis | 439 | -0.4648286 | -1.621206 | 6.0e-07 | 0.0001794 | 0.0001554 | 4251 | tags=33%, list=19%, signal=27% |
| C0031106 | Aggressive Periodontitis | 159 | -0.5693921 | -1.849226 | 6.0e-07 | 0.0001794 | 0.0001554 | 3208 | tags=38%, list=15%, signal=33% |
| C0014060 | Encephalitis, St. Louis | 234 | -0.5262600 | -1.762663 | 9.0e-07 | 0.0002435 | 0.0002109 | 4291 | tags=37%, list=20%, signal=30% |
| C0024314 | Lymphoproliferative Disorders | 258 | -0.5118530 | -1.720976 | 1.0e-06 | 0.0002593 | 0.0002246 | 3762 | tags=33%, list=17%, signal=28% |
| C0023440 | Acute Erythroblastic Leukemia | 264 | -0.4965192 | -1.671357 | 1.9e-06 | 0.0004753 | 0.0004118 | 4391 | tags=26%, list=20%, signal=21% |
| C1527336 | Sjogren’s Syndrome | 414 | -0.4546769 | -1.585085 | 2.4e-06 | 0.0005934 | 0.0005140 | 3238 | tags=26%, list=15%, signal=22% |
| C0022568 | Keratitis | 143 | -0.5763912 | -1.855153 | 2.7e-06 | 0.0006116 | 0.0005298 | 4105 | tags=37%, list=19%, signal=30% |
| C0011311 | Dengue Fever | 315 | -0.4879311 | -1.670805 | 2.7e-06 | 0.0006116 | 0.0005298 | 4413 | tags=30%, list=20%, signal=24% |
| C0042109 | Urticaria | 154 | -0.5681084 | -1.839187 | 2.8e-06 | 0.0006116 | 0.0005298 | 4225 | tags=42%, list=19%, signal=34% |
| id | hgnc | baseMean | log2FoldChange | lfcSE | stat | pvalue | padj |
|---|---|---|---|---|---|---|---|
| ENSG00000004799 | PDK4 | 1774.517985 | 1.8073989 | 0.3037663 | 5.949964 | 0.0000000 | 0.0000154 |
| ENSG00000070540 | WIPI1 | 5069.961230 | 0.6430208 | 0.1568302 | 4.100108 | 0.0000413 | 0.0400580 |
| ENSG00000071242 | RPS6KA2 | 10519.642406 | 0.6464711 | 0.1690594 | 3.823928 | 0.0001313 | 0.0877147 |
| ENSG00000078898 | BPIFB2 | 1321.895646 | -2.6947052 | 0.7193037 | -3.746269 | 0.0001795 | 0.0980175 |
| ENSG00000085265 | FCN1 | 111.670183 | -2.0733475 | 0.5542423 | -3.740868 | 0.0001834 | 0.0980175 |
| ENSG00000087495 | PHACTR3 | 385.304675 | 2.7849520 | 0.4549762 | 6.121093 | 0.0000000 | 0.0000071 |
| ENSG00000096060 | FKBP5 | 9841.538419 | 2.7571923 | 0.3597548 | 7.664087 | 0.0000000 | 0.0000000 |
| ENSG00000101916 | TLR8 | 100.381433 | -1.7918440 | 0.4196173 | -4.270187 | 0.0000195 | 0.0250887 |
| ENSG00000103942 | HOMER2 | 5443.869611 | 0.6212210 | 0.1474074 | 4.214312 | 0.0000251 | 0.0303062 |
| ENSG00000109906 | ZBTB16 | 19666.248173 | 2.9924653 | 0.5195812 | 5.759380 | 0.0000000 | 0.0000323 |
| ENSG00000111666 | CHPT1 | 5157.328919 | 0.7817596 | 0.2016591 | 3.876640 | 0.0001059 | 0.0760657 |
| ENSG00000117152 | RGS4 | 285.956946 | -1.8641446 | 0.5003152 | -3.725940 | 0.0001946 | 0.0993828 |
| ENSG00000117479 | SLC19A2 | 2324.977435 | 0.7186033 | 0.1898646 | 3.784819 | 0.0001538 | 0.0937895 |
| ENSG00000119138 | KLF9 | 2951.813358 | 1.0598054 | 0.2728519 | 3.884178 | 0.0001027 | 0.0760657 |
| ENSG00000125538 | IL1B | 46.029969 | -1.5333992 | 0.4060738 | -3.776159 | 0.0001593 | 0.0937895 |
| ENSG00000151012 | SLC7A11 | 3805.816974 | -3.0110722 | 0.6992094 | -4.306395 | 0.0000166 | 0.0238357 |
| ENSG00000154277 | UCHL1 | 422.690325 | -2.5745162 | 0.6577718 | -3.913996 | 0.0000908 | 0.0719456 |
| ENSG00000157514 | TSC22D3 | 4388.619107 | 1.2398592 | 0.2022905 | 6.129104 | 0.0000000 | 0.0000071 |
| ENSG00000163053 | SLC16A14 | 1065.539780 | 1.1320323 | 0.2997478 | 3.776616 | 0.0001590 | 0.0937895 |
| ENSG00000163563 | MNDA | 368.878123 | -1.8258115 | 0.4526803 | -4.033336 | 0.0000550 | 0.0505540 |
| ENSG00000163884 | KLF15 | 621.988003 | 1.4280049 | 0.3300281 | 4.326919 | 0.0000151 | 0.0231683 |
| ENSG00000170820 | FSHR | 49.752910 | -2.5502589 | 0.6467712 | -3.943062 | 0.0000804 | 0.0684790 |
| ENSG00000171658 | NMRAL2P | 512.290404 | -2.9991002 | 0.6585254 | -4.554267 | 0.0000053 | 0.0120819 |
| ENSG00000173391 | OLR1 | 98.232524 | -2.0428788 | 0.4937278 | -4.137662 | 0.0000351 | 0.0366540 |
| ENSG00000186407 | CD300E | 23.227454 | -2.4125659 | 0.5651571 | -4.268841 | 0.0000196 | 0.0250887 |
| ENSG00000188269 | OR7A5 | 68.793359 | 2.3794778 | 0.5061446 | 4.701182 | 0.0000026 | 0.0072383 |
| ENSG00000188536 | HBA2 | 637.909397 | -3.0218702 | 0.8015523 | -3.770022 | 0.0001632 | 0.0937895 |
| ENSG00000196208 | GREB1 | 211.601669 | 1.7238554 | 0.4493969 | 3.835931 | 0.0001251 | 0.0871193 |
| ENSG00000197629 | MPEG1 | 556.151502 | -1.3979913 | 0.3560533 | -3.926354 | 0.0000862 | 0.0707904 |
| ENSG00000211951 | IGHV2-26 | 27.070247 | -3.3078799 | 0.7441421 | -4.445226 | 0.0000088 | 0.0168158 |
| ENSG00000227610 | FRMPD3-AS1 | 47.872542 | 2.1280625 | 0.5484509 | 3.880133 | 0.0001044 | 0.0760657 |
| ENSG00000230978 | LINC00160 | 8.311309 | 2.1746036 | 0.5723650 | 3.799330 | 0.0001451 | 0.0926264 |
| ENSG00000235303 | 14.970215 | -1.1506977 | 0.3062695 | -3.757141 | 0.0001719 | 0.0963410 | |
| ENSG00000248165 | 685.740404 | -2.8353226 | 0.6055194 | -4.682464 | 0.0000028 | 0.0072383 | |
| ENSG00000249717 | PARM1-AS1 | 66.066138 | -2.6893581 | 0.6147719 | -4.374563 | 0.0000122 | 0.0199749 |
| ENSG00000250994 | 73.980616 | 0.9156424 | 0.2453721 | 3.731648 | 0.0001902 | 0.0993655 | |
| ENSG00000251003 | ZFPM2-AS1 | 589.691311 | -2.1213612 | 0.5177677 | -4.097129 | 0.0000418 | 0.0400580 |
| ENSG00000258038 | LINC02327 | 28.764284 | -3.3843759 | 0.8860163 | -3.819767 | 0.0001336 | 0.0877147 |
| ENSG00000259479 | SORD2P | 1389.845136 | 2.4724575 | 0.6228792 | 3.969401 | 0.0000721 | 0.0636925 |
| ENSG00000260186 | LINC02137 | 165.324032 | 1.6962819 | 0.4036752 | 4.202096 | 0.0000264 | 0.0303898 |
| ENSG00000262039 | 39.871203 | 1.3363845 | 0.3048105 | 4.384313 | 0.0000116 | 0.0199749 | |
| ENSG00000267594 | CYP4F24P | 72.684971 | -2.4885693 | 0.5990410 | -4.154255 | 0.0000326 | 0.0357165 |
| ENSG00000267653 | 19.727419 | 3.4695816 | 0.7069850 | 4.907574 | 0.0000009 | 0.0030275 | |
| ENSG00000259176 | NA | 23.971388 | 2.5873311 | 0.5722578 | 4.521269 | 0.0000061 | 0.0128433 |
| id | hgnc | baseMean | log2FoldChange | lfcSE | stat | pvalue | padj |
|---|---|---|---|---|---|---|---|
| ENSG00000008516 | MMP25 | 47.814331 | -0.7299385 | 0.4159684 | -1.7547932 | 0.0792947 | 0.9997399 |
| ENSG00000035862 | TIMP2 | 2017.994671 | -0.4488761 | 0.4639810 | -0.9674449 | 0.3333217 | 0.9997399 |
| ENSG00000049089 | COL9A2 | 386.467175 | 0.3580127 | 0.3394490 | 1.0546877 | 0.2915682 | 0.9997399 |
| ENSG00000050767 | COL23A1 | 1797.394008 | -0.5426821 | 0.4435741 | -1.2234307 | 0.2211671 | 0.9997399 |
| ENSG00000060718 | COL11A1 | 29.954148 | -0.8439206 | 0.5376557 | -1.5696302 | 0.1165012 | 0.9997399 |
| ENSG00000065618 | COL17A1 | 2627.563451 | -0.1407201 | 0.4879729 | -0.2883770 | 0.7730582 | 0.9997399 |
| ENSG00000080573 | COL5A3 | 333.831459 | -0.2943238 | 0.5489190 | -0.5361880 | 0.5918286 | 0.9997399 |
| ENSG00000081052 | COL4A4 | 415.076341 | 0.1635917 | 0.3886385 | 0.4209354 | 0.6738022 | 0.9997399 |
| ENSG00000082293 | COL19A1 | 1865.136149 | -0.0534734 | 0.5306025 | -0.1007786 | 0.9197262 | 0.9997399 |
| ENSG00000084636 | COL16A1 | 2277.626966 | -0.2495544 | 0.3468906 | -0.7194037 | 0.4718922 | 0.9997399 |
| ENSG00000087245 | MMP2 | 1910.858902 | -0.4224581 | 0.5245800 | -0.8053264 | 0.4206314 | 0.9997399 |
| ENSG00000092758 | COL9A3 | 64.032653 | -0.6456897 | 0.3770181 | -1.7126228 | 0.0867820 | 0.9997399 |
| ENSG00000099953 | MMP11 | 40.287877 | -0.4082052 | 0.3112927 | -1.3113230 | 0.1897487 | 0.9997399 |
| ENSG00000100234 | TIMP3 | 13237.910809 | 0.0601797 | 0.4590161 | 0.1311058 | 0.8956916 | 0.9997399 |
| ENSG00000100985 | MMP9 | 13.945728 | 0.2194338 | 0.6796597 | 0.3228583 | 0.7468025 | 0.9997399 |
| ENSG00000101203 | COL20A1 | 2.608173 | -0.0299840 | 0.7574789 | -0.0395839 | 0.9684248 | NA |
| ENSG00000102265 | TIMP1 | 1329.899651 | -0.2097742 | 0.2393428 | -0.8764594 | 0.3807804 | 0.9997399 |
| ENSG00000102996 | MMP15 | 259.630827 | -0.1744123 | 0.2637980 | -0.6611586 | 0.5085106 | 0.9997399 |
| ENSG00000108821 | COL1A1 | 1250.766296 | -0.8890248 | 0.4970015 | -1.7887768 | 0.0736508 | 0.9997399 |
| ENSG00000111799 | COL12A1 | 4539.497308 | -0.2735144 | 0.4351595 | -0.6285383 | 0.5296514 | 0.9997399 |
| ENSG00000112280 | COL9A1 | 23.330406 | -0.1182665 | 0.4332886 | -0.2729509 | 0.7848909 | 0.9997399 |
| ENSG00000114270 | COL7A1 | 4754.168226 | -0.3950842 | 0.4129055 | -0.9568394 | 0.3386483 | 0.9997399 |
| ENSG00000118113 | MMP8 | 1.302535 | -2.6725619 | 1.0098230 | -2.6465646 | 0.0081314 | NA |
| ENSG00000123342 | MMP19 | 126.856936 | -0.0005803 | 0.3901390 | -0.0014875 | 0.9988132 | 0.9999329 |
| ENSG00000123500 | COL10A1 | 42.034741 | -0.5144431 | 0.5141438 | -1.0005821 | 0.3170289 | 0.9997399 |
| ENSG00000125966 | MMP24 | 54.115356 | -0.0458827 | 0.3330566 | -0.1377624 | 0.8904282 | 0.9997399 |
| ENSG00000130635 | COL5A1 | 2973.745763 | -0.9567757 | 0.4878958 | -1.9610247 | 0.0498761 | 0.9625525 |
| ENSG00000134871 | COL4A2 | 7220.286767 | -0.3562504 | 0.5629478 | -0.6328302 | 0.5268445 | 0.9997399 |
| ENSG00000137673 | MMP7 | 87.850186 | -0.3493016 | 0.5000304 | -0.6985608 | 0.4848266 | 0.9997399 |
| ENSG00000137674 | MMP20 | 2.280935 | -0.9137534 | 0.5505163 | -1.6598117 | 0.0969523 | NA |
| ENSG00000137675 | MMP27 | 36.109287 | -0.6663520 | 0.5771123 | -1.1546315 | 0.2482414 | 0.9997399 |
| ENSG00000137745 | MMP13 | 164.396539 | -0.9656219 | 0.4466950 | -2.1617032 | 0.0306411 | 0.8182963 |
| ENSG00000142156 | COL6A1 | 2292.773568 | -0.1282887 | 0.5398690 | -0.2376293 | 0.8121686 | 0.9997399 |
| ENSG00000142173 | COL6A2 | 3760.422733 | -0.2263442 | 0.5781825 | -0.3914753 | 0.6954459 | 0.9997399 |
| ENSG00000144810 | COL8A1 | 3009.510362 | 0.1409280 | 0.4174245 | 0.3376132 | 0.7356547 | 0.9997399 |
| ENSG00000149968 | MMP3 | 7.315606 | 0.2899462 | 0.5696511 | 0.5089892 | 0.6107598 | NA |
| ENSG00000154485 | MMP21 | 22.801905 | 0.1610517 | 0.2395699 | 0.6722533 | 0.5014225 | 0.9997399 |
| ENSG00000156103 | MMP16 | 1643.589280 | 0.0596325 | 0.4575780 | 0.1303220 | 0.8963117 | 0.9997399 |
| ENSG00000157150 | TIMP4 | 296.721191 | 0.0129175 | 0.5545784 | 0.0232924 | 0.9814170 | 0.9997399 |
| ENSG00000157227 | MMP14 | 1919.957690 | -0.3502053 | 0.1793489 | -1.9526481 | 0.0508613 | 0.9638958 |
| ENSG00000160963 | COL26A1 | 70.986141 | -0.8950093 | 0.3341566 | -2.6784129 | 0.0073972 | 0.4899418 |
| ENSG00000163359 | COL6A3 | 8648.461070 | -0.0885335 | 0.4698139 | -0.1884437 | 0.8505289 | 0.9997399 |
| ENSG00000164692 | COL1A2 | 5960.134146 | -0.7604720 | 0.5302002 | -1.4343111 | 0.1514835 | 0.9997399 |
| ENSG00000166670 | MMP10 | 1432.539174 | -0.2000672 | 0.6276028 | -0.3187800 | 0.7498934 | 0.9997399 |
| ENSG00000168542 | COL3A1 | 8154.537217 | -0.6517421 | 0.5249876 | -1.2414429 | 0.2144422 | 0.9997399 |
| ENSG00000169031 | COL4A3 | 263.147839 | 0.1541405 | 0.4007592 | 0.3846212 | 0.7005181 | 0.9997399 |
| ENSG00000169436 | COL22A1 | 144.692102 | -0.5120219 | 0.3960596 | -1.2927901 | 0.1960837 | 0.9997399 |
| ENSG00000171502 | COL24A1 | 1347.161170 | -0.0024750 | 0.2059044 | -0.0120201 | 0.9904096 | 0.9997399 |
| ENSG00000171812 | COL8A2 | 167.235545 | -0.6708193 | 0.4564343 | -1.4696952 | 0.1416443 | 0.9997399 |
| ENSG00000172752 | COL6A5 | 424.199656 | -0.1578098 | 0.6223145 | -0.2535853 | 0.7998159 | 0.9997399 |
| ENSG00000182871 | COL18A1 | 2389.763209 | -0.7129194 | 0.4466833 | -1.5960287 | 0.1104824 | 0.9997399 |
| ENSG00000187498 | COL4A1 | 5728.448623 | -0.4255553 | 0.5366124 | -0.7930404 | 0.4277543 | 0.9997399 |
| ENSG00000187955 | COL14A1 | 4041.229187 | -0.4447637 | 0.3976846 | -1.1183830 | 0.2634034 | 0.9997399 |
| ENSG00000188153 | COL4A5 | 39671.258609 | -0.0626492 | 0.2442341 | -0.2565131 | 0.7975547 | 0.9997399 |
| ENSG00000188517 | COL25A1 | 1879.068967 | -0.2395182 | 0.2824181 | -0.8480979 | 0.3963835 | 0.9997399 |
| ENSG00000196739 | COL27A1 | 2160.128640 | -0.4148415 | 0.3364760 | -1.2329009 | 0.2176127 | 0.9997399 |
| ENSG00000197467 | COL13A1 | 1933.455231 | -0.2268017 | 0.5820697 | -0.3896470 | 0.6967976 | 0.9997399 |
| ENSG00000197565 | COL4A6 | 12907.999858 | -0.1371358 | 0.3582945 | -0.3827460 | 0.7019081 | 0.9997399 |
| ENSG00000198598 | MMP17 | 106.982523 | -0.6663581 | 0.4831654 | -1.3791512 | 0.1678482 | 0.9997399 |
| ENSG00000204248 | COL11A2 | 55.943700 | -0.1796276 | 0.3481300 | -0.5159784 | 0.6058695 | 0.9997399 |
| ENSG00000204262 | COL5A2 | 4827.335133 | 0.0950911 | 0.2530289 | 0.3758113 | 0.7070572 | 0.9997399 |
| ENSG00000204291 | COL15A1 | 7301.702970 | -0.5394266 | 0.5283291 | -1.0210048 | 0.3072522 | 0.9997399 |
| ENSG00000206384 | COL6A6 | 671.641676 | -0.6482451 | 0.6373286 | -1.0171285 | 0.3090923 | 0.9997399 |
| ENSG00000215018 | COL28A1 | 9611.717135 | 0.3921716 | 0.4097600 | 0.9570765 | 0.3385286 | 0.9997399 |